Advertisement

Index by author

April 01, 1995; Volume 23,Issue 4

A

  1. Angus, P W

    1. Effects of chronic left ventricular failure on hepatic oxygenation and theophylline elimination in the rat.
      P W Angus, C Y Ng, H Ghabrial, D J Morgan and R A Smallwood
      Drug Metabolism and Disposition April 1995, 23 (4) 485-489;

B

  1. Bhalla, K N

    1. Taxol metabolism and disposition in cancer patients.
      T Walle, U K Walle, G N Kumar and K N Bhalla
      Drug Metabolism and Disposition April 1995, 23 (4) 506-512;

  2. Bockbrader, H N

    1. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.
      L L Radulovic, D Türck, A von Hodenberg, K O Vollmer, W P McNally, P D DeHart, B J Hanson, H N Bockbrader and T Chang
      Drug Metabolism and Disposition April 1995, 23 (4) 441-448;

  3. Brendel, K

    1. Biotransformation of sevoflurane by rat neonate liver slices.
      A K Payne, S E Morgan, A J Gandolfi and K Brendel
      Drug Metabolism and Disposition April 1995, 23 (4) 497-500;

C

  1. Chang, T

    1. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.
      L L Radulovic, D Türck, A von Hodenberg, K O Vollmer, W P McNally, P D DeHart, B J Hanson, H N Bockbrader and T Chang
      Drug Metabolism and Disposition April 1995, 23 (4) 441-448;

  2. Cho, J Y

    1. Differential expression of rat microsomal epoxide hydrolase gene by imidazole and triazole antimycotic agents.
      S G Kim, J Y Cho and K H Jung
      Drug Metabolism and Disposition April 1995, 23 (4) 460-464;

  3. Chow, M S

    1. A method of determining the in vivo drug release rate constant of sustained-release preparation.
      H Sun and M S Chow
      Drug Metabolism and Disposition April 1995, 23 (4) 449-454;

  4. Coldham, N G

    1. Imidocarb residues in edible bovine tissues and in vitro assessment of imidocarb metabolism and cytotoxicity.
      N G Coldham, A S Moore, M Dave, P J Graham, S Sivapathasundaram, B G Lake and M J Sauer
      Drug Metabolism and Disposition April 1995, 23 (4) 501-505;

  5. Coutts, R T

    1. Lack of residual effects of diethyl ether, methoxyflurane, and sodium pentobarbital on lidocaine metabolism in a single-pass isolated rat liver perfusion system.
      L Y Ngo, Y K Tam and R T Coutts
      Drug Metabolism and Disposition April 1995, 23 (4) 525-528;

D

  1. Dave, M

    1. Imidocarb residues in edible bovine tissues and in vitro assessment of imidocarb metabolism and cytotoxicity.
      N G Coldham, A S Moore, M Dave, P J Graham, S Sivapathasundaram, B G Lake and M J Sauer
      Drug Metabolism and Disposition April 1995, 23 (4) 501-505;

  2. DeHart, P D

    1. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.
      L L Radulovic, D Türck, A von Hodenberg, K O Vollmer, W P McNally, P D DeHart, B J Hanson, H N Bockbrader and T Chang
      Drug Metabolism and Disposition April 1995, 23 (4) 441-448;

G

  1. Gandolfi, A J

    1. Biotransformation of sevoflurane by rat neonate liver slices.
      A K Payne, S E Morgan, A J Gandolfi and K Brendel
      Drug Metabolism and Disposition April 1995, 23 (4) 497-500;

  2. Ghabrial, H

    1. Effects of chronic left ventricular failure on hepatic oxygenation and theophylline elimination in the rat.
      P W Angus, C Y Ng, H Ghabrial, D J Morgan and R A Smallwood
      Drug Metabolism and Disposition April 1995, 23 (4) 485-489;

  3. Graham, P J

    1. Imidocarb residues in edible bovine tissues and in vitro assessment of imidocarb metabolism and cytotoxicity.
      N G Coldham, A S Moore, M Dave, P J Graham, S Sivapathasundaram, B G Lake and M J Sauer
      Drug Metabolism and Disposition April 1995, 23 (4) 501-505;

H

  1. Hanson, B J

    1. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.
      L L Radulovic, D Türck, A von Hodenberg, K O Vollmer, W P McNally, P D DeHart, B J Hanson, H N Bockbrader and T Chang
      Drug Metabolism and Disposition April 1995, 23 (4) 441-448;

  2. Hickman, D

    1. Dapsone acetylation by human liver arylamine N-acetyltransferases and interaction with antiopportunistic infection drugs.
      J R Palamanda, D Hickman, A Ward, E Sim, M Romkes-Sparks and J D Unadkat
      Drug Metabolism and Disposition April 1995, 23 (4) 473-477;

J

  1. Jung, K H

    1. Differential expression of rat microsomal epoxide hydrolase gene by imidazole and triazole antimycotic agents.
      S G Kim, J Y Cho and K H Jung
      Drug Metabolism and Disposition April 1995, 23 (4) 460-464;

K

  1. Kadlubar, F F

    1. Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice.
      D X Lin, N P Lang and F F Kadlubar
      Drug Metabolism and Disposition April 1995, 23 (4) 518-524;

  2. Kharasch, E D

    1. Catalytic role of cytochrome P4503A4 in multiple pathways of alfentanil metabolism.
      R B Labroo, K E Thummel, K L Kunze, T Podoll, W F Trager and E D Kharasch
      Drug Metabolism and Disposition April 1995, 23 (4) 490-496;

  3. Kim, S G

    1. Differential expression of rat microsomal epoxide hydrolase gene by imidazole and triazole antimycotic agents.
      S G Kim, J Y Cho and K H Jung
      Drug Metabolism and Disposition April 1995, 23 (4) 460-464;

  4. Kumar, G N

    1. Taxol metabolism and disposition in cancer patients.
      T Walle, U K Walle, G N Kumar and K N Bhalla
      Drug Metabolism and Disposition April 1995, 23 (4) 506-512;

  5. Kunze, K L

    1. Catalytic role of cytochrome P4503A4 in multiple pathways of alfentanil metabolism.
      R B Labroo, K E Thummel, K L Kunze, T Podoll, W F Trager and E D Kharasch
      Drug Metabolism and Disposition April 1995, 23 (4) 490-496;

L

  1. Labroo, R B

    1. Catalytic role of cytochrome P4503A4 in multiple pathways of alfentanil metabolism.
      R B Labroo, K E Thummel, K L Kunze, T Podoll, W F Trager and E D Kharasch
      Drug Metabolism and Disposition April 1995, 23 (4) 490-496;

  2. Lake, B G

    1. Imidocarb residues in edible bovine tissues and in vitro assessment of imidocarb metabolism and cytotoxicity.
      N G Coldham, A S Moore, M Dave, P J Graham, S Sivapathasundaram, B G Lake and M J Sauer
      Drug Metabolism and Disposition April 1995, 23 (4) 501-505;

  3. Lang, N P

    1. Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice.
      D X Lin, N P Lang and F F Kadlubar
      Drug Metabolism and Disposition April 1995, 23 (4) 518-524;

  4. Lin, D X

    1. Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice.
      D X Lin, N P Lang and F F Kadlubar
      Drug Metabolism and Disposition April 1995, 23 (4) 518-524;

M

  1. Mautz, D S

    1. Regioselective and stereoselective oxidation of metoprolol and bufuralol catalyzed by microsomes containing cDNA-expressed human P4502D6.
      D S Mautz, W L Nelson and D D Shen
      Drug Metabolism and Disposition April 1995, 23 (4) 513-517;

  2. McNally, W P

    1. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.
      L L Radulovic, D Türck, A von Hodenberg, K O Vollmer, W P McNally, P D DeHart, B J Hanson, H N Bockbrader and T Chang
      Drug Metabolism and Disposition April 1995, 23 (4) 441-448;

  3. McNamara, P J

    1. Acitretin elimination in Sprague-Dawley rats pretreated with phenobarbital or beta-naphthoflavone.
      D S Small and P J McNamara
      Drug Metabolism and Disposition April 1995, 23 (4) 465-472;

  4. Moore, A S

    1. Imidocarb residues in edible bovine tissues and in vitro assessment of imidocarb metabolism and cytotoxicity.
      N G Coldham, A S Moore, M Dave, P J Graham, S Sivapathasundaram, B G Lake and M J Sauer
      Drug Metabolism and Disposition April 1995, 23 (4) 501-505;

  5. Morgan, D J

    1. Effects of chronic left ventricular failure on hepatic oxygenation and theophylline elimination in the rat.
      P W Angus, C Y Ng, H Ghabrial, D J Morgan and R A Smallwood
      Drug Metabolism and Disposition April 1995, 23 (4) 485-489;

  6. Morgan, S E

    1. Biotransformation of sevoflurane by rat neonate liver slices.
      A K Payne, S E Morgan, A J Gandolfi and K Brendel
      Drug Metabolism and Disposition April 1995, 23 (4) 497-500;

N

  1. Nelson, W L

    1. Regioselective and stereoselective oxidation of metoprolol and bufuralol catalyzed by microsomes containing cDNA-expressed human P4502D6.
      D S Mautz, W L Nelson and D D Shen
      Drug Metabolism and Disposition April 1995, 23 (4) 513-517;

  2. Ng, C Y

    1. Effects of chronic left ventricular failure on hepatic oxygenation and theophylline elimination in the rat.
      P W Angus, C Y Ng, H Ghabrial, D J Morgan and R A Smallwood
      Drug Metabolism and Disposition April 1995, 23 (4) 485-489;

  3. Ngo, L Y

    1. Lack of residual effects of diethyl ether, methoxyflurane, and sodium pentobarbital on lidocaine metabolism in a single-pass isolated rat liver perfusion system.
      L Y Ngo, Y K Tam and R T Coutts
      Drug Metabolism and Disposition April 1995, 23 (4) 525-528;

O

  1. Ouellet, D M

    1. Biliary excretion and enterohepatic recirculation of morphine-3-glucuronide in rats.
      D M Ouellet and G M Pollack
      Drug Metabolism and Disposition April 1995, 23 (4) 478-484;

P

  1. Palamanda, J R

    1. Dapsone acetylation by human liver arylamine N-acetyltransferases and interaction with antiopportunistic infection drugs.
      J R Palamanda, D Hickman, A Ward, E Sim, M Romkes-Sparks and J D Unadkat
      Drug Metabolism and Disposition April 1995, 23 (4) 473-477;

  2. Payne, A K

    1. Biotransformation of sevoflurane by rat neonate liver slices.
      A K Payne, S E Morgan, A J Gandolfi and K Brendel
      Drug Metabolism and Disposition April 1995, 23 (4) 497-500;

  3. Podoll, T

    1. Catalytic role of cytochrome P4503A4 in multiple pathways of alfentanil metabolism.
      R B Labroo, K E Thummel, K L Kunze, T Podoll, W F Trager and E D Kharasch
      Drug Metabolism and Disposition April 1995, 23 (4) 490-496;

  4. Pollack, G M

    1. Biliary excretion and enterohepatic recirculation of morphine-3-glucuronide in rats.
      D M Ouellet and G M Pollack
      Drug Metabolism and Disposition April 1995, 23 (4) 478-484;

R

  1. Radulovic, L L

    1. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.
      L L Radulovic, D Türck, A von Hodenberg, K O Vollmer, W P McNally, P D DeHart, B J Hanson, H N Bockbrader and T Chang
      Drug Metabolism and Disposition April 1995, 23 (4) 441-448;

  2. Romkes-Sparks, M

    1. Dapsone acetylation by human liver arylamine N-acetyltransferases and interaction with antiopportunistic infection drugs.
      J R Palamanda, D Hickman, A Ward, E Sim, M Romkes-Sparks and J D Unadkat
      Drug Metabolism and Disposition April 1995, 23 (4) 473-477;

  3. Runge-Morris, M

    1. Effects of streptozotocin-induced diabetes on rat liver sulfotransferase gene expression.
      M Runge-Morris and C Vento
      Drug Metabolism and Disposition April 1995, 23 (4) 455-459;

S

  1. Sauer, M J

    1. Imidocarb residues in edible bovine tissues and in vitro assessment of imidocarb metabolism and cytotoxicity.
      N G Coldham, A S Moore, M Dave, P J Graham, S Sivapathasundaram, B G Lake and M J Sauer
      Drug Metabolism and Disposition April 1995, 23 (4) 501-505;

  2. Shen, D D

    1. Regioselective and stereoselective oxidation of metoprolol and bufuralol catalyzed by microsomes containing cDNA-expressed human P4502D6.
      D S Mautz, W L Nelson and D D Shen
      Drug Metabolism and Disposition April 1995, 23 (4) 513-517;

  3. Sim, E

    1. Dapsone acetylation by human liver arylamine N-acetyltransferases and interaction with antiopportunistic infection drugs.
      J R Palamanda, D Hickman, A Ward, E Sim, M Romkes-Sparks and J D Unadkat
      Drug Metabolism and Disposition April 1995, 23 (4) 473-477;

  4. Sivapathasundaram, S

    1. Imidocarb residues in edible bovine tissues and in vitro assessment of imidocarb metabolism and cytotoxicity.
      N G Coldham, A S Moore, M Dave, P J Graham, S Sivapathasundaram, B G Lake and M J Sauer
      Drug Metabolism and Disposition April 1995, 23 (4) 501-505;

  5. Small, D S

    1. Acitretin elimination in Sprague-Dawley rats pretreated with phenobarbital or beta-naphthoflavone.
      D S Small and P J McNamara
      Drug Metabolism and Disposition April 1995, 23 (4) 465-472;

  6. Smallwood, R A

    1. Effects of chronic left ventricular failure on hepatic oxygenation and theophylline elimination in the rat.
      P W Angus, C Y Ng, H Ghabrial, D J Morgan and R A Smallwood
      Drug Metabolism and Disposition April 1995, 23 (4) 485-489;

  7. Sun, H

    1. A method of determining the in vivo drug release rate constant of sustained-release preparation.
      H Sun and M S Chow
      Drug Metabolism and Disposition April 1995, 23 (4) 449-454;

T

  1. Tam, Y K

    1. Lack of residual effects of diethyl ether, methoxyflurane, and sodium pentobarbital on lidocaine metabolism in a single-pass isolated rat liver perfusion system.
      L Y Ngo, Y K Tam and R T Coutts
      Drug Metabolism and Disposition April 1995, 23 (4) 525-528;

  2. Thummel, K E

    1. Catalytic role of cytochrome P4503A4 in multiple pathways of alfentanil metabolism.
      R B Labroo, K E Thummel, K L Kunze, T Podoll, W F Trager and E D Kharasch
      Drug Metabolism and Disposition April 1995, 23 (4) 490-496;

  3. Trager, W F

    1. Catalytic role of cytochrome P4503A4 in multiple pathways of alfentanil metabolism.
      R B Labroo, K E Thummel, K L Kunze, T Podoll, W F Trager and E D Kharasch
      Drug Metabolism and Disposition April 1995, 23 (4) 490-496;

  4. Türck, D

    1. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.
      L L Radulovic, D Türck, A von Hodenberg, K O Vollmer, W P McNally, P D DeHart, B J Hanson, H N Bockbrader and T Chang
      Drug Metabolism and Disposition April 1995, 23 (4) 441-448;

U

  1. Unadkat, J D

    1. Dapsone acetylation by human liver arylamine N-acetyltransferases and interaction with antiopportunistic infection drugs.
      J R Palamanda, D Hickman, A Ward, E Sim, M Romkes-Sparks and J D Unadkat
      Drug Metabolism and Disposition April 1995, 23 (4) 473-477;

V

  1. Vento, C

    1. Effects of streptozotocin-induced diabetes on rat liver sulfotransferase gene expression.
      M Runge-Morris and C Vento
      Drug Metabolism and Disposition April 1995, 23 (4) 455-459;

  2. Vollmer, K O

    1. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.
      L L Radulovic, D Türck, A von Hodenberg, K O Vollmer, W P McNally, P D DeHart, B J Hanson, H N Bockbrader and T Chang
      Drug Metabolism and Disposition April 1995, 23 (4) 441-448;

  3. von Hodenberg, A

    1. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.
      L L Radulovic, D Türck, A von Hodenberg, K O Vollmer, W P McNally, P D DeHart, B J Hanson, H N Bockbrader and T Chang
      Drug Metabolism and Disposition April 1995, 23 (4) 441-448;

W

  1. Walle, T

    1. Taxol metabolism and disposition in cancer patients.
      T Walle, U K Walle, G N Kumar and K N Bhalla
      Drug Metabolism and Disposition April 1995, 23 (4) 506-512;

  2. Walle, U K

    1. Taxol metabolism and disposition in cancer patients.
      T Walle, U K Walle, G N Kumar and K N Bhalla
      Drug Metabolism and Disposition April 1995, 23 (4) 506-512;

  3. Ward, A

    1. Dapsone acetylation by human liver arylamine N-acetyltransferases and interaction with antiopportunistic infection drugs.
      J R Palamanda, D Hickman, A Ward, E Sim, M Romkes-Sparks and J D Unadkat
      Drug Metabolism and Disposition April 1995, 23 (4) 473-477;
Back to top

In this issue

Advertisement